image
Lumos Pharma, Inc. LUMO
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 4.33
0 %
$ 37.4 M
Market Cap
-1.01
P/E
BALANCE SHEET
40.6 M ASSETS
-43.79%
Growth Rates
1Year -43.79%
3Years -31.96%
5Years -20.86%
7Years -18.81%
10Years -5.37%
13.3 M LIABILITIES
4.92%
Growth Rates
1Year 4.92%
3Years 2.28%
5Years -3.33%
7Years -16.03%
10Years 0.87%
27.3 M EQUITY
-54.17%
Growth Rates
1Year -54.17%
3Years -38.36%
5Years -25.01%
7Years -19.94%
10Years -7.31%
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition Lumos Pharma, Inc.
image
Current Assets 40 M
Cash & Short-Term Investments 36.1 M
Receivables 210 K
Other Current Assets 3.75 M
Non-Current Assets 603 K
Long-Term Investments 0
PP&E 603 K
Other Non-Current Assets 0
Current Liabilities 7.03 M
Accounts Payable 890 K
Short-Term Debt 564 K
Other Current Liabilities 5.58 M
Non-Current Liabilities 6.3 M
Long-Term Debt 303 K
Other Non-Current Liabilities 6 M

Balance Sheet

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013 Dec-2012 Dec-2011 Dec-2010 Dec-2009 Dec-2008
ASSETS
Cash & Cash Equivalents 35.1 56.0 94.8 98.7 90.5 120.7 158.7 131.5 195.6 190.4 61.3 20.2 39.5 10.6 15.2 6.3
Short Term Investments 1.0 11.4 0 0 0 0 0 0 2.2 12.4 0.2 1.5 2.5 2.3 0 0
Receivables 0.2 0.2 0.1 26.3 35 K 0.8 10.5 30.5 5.4 0 1.7 0.7 0.4 0.8 1.6 0.6
Inventory 0 0 0 0 0 0 0 0 (5.4) 3.7 0 (0.7) 0.4 0 0.1 50 K
Other Current Assets 3.7 4.4 4.7 3.5 82 K 11.1 12.5 5.9 5.0 8.3 0.8 0.9 0.4 1.0 0.1 1.9
Total Current Assets 40.0 72.0 99.7 128.4 94.4 127.1 175.5 167.9 208.1 230.5 64.0 23.4 42.8 14.6 18.9 8.8
PP&E 0.6 0.3 0.6 0.6 2.4 3.7 5.1 6.8 10.4 7.6 6.6 6.0 5.6 5.4 2.9 1.0
Intangible Assets 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Goodwill 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Long Term Investments 0 0 0 0 0 0.1 0.1 0 0 0 0 0 0 0 0 0
Other Long Term Assets 0 (0.3) (0.6) (0.6) 0 0 0 0 0 (15.6) 0 0 0 0 0.8 0.8
Other Assets 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Total Assets 40.6 72.3 100.3 129.0 96.8 130.9 180.7 174.7 218.5 238.1 70.6 29.4 48.4 20.1 22.7 10.6
LIABILITIES
Accounts Payable 0.9 0.3 0.6 0.2 0.4 0.6 9.3 22.9 3.7 2.4 0.6 1.0 1.7 0.6 1.1 0.6
Short Term Debt 0.6 0.5 0.7 0.6 0.2 61 K (12.3) (14.1) 0.6 0.2 0.2 0.2 6.2 0.2 35 K 4 K
Other Current Liabilities 5.6 6.0 3.8 5.6 0.7 8.2 12.6 14.4 8.8 9.4 2.8 1.7 2.8 1.6 1.2 1.2
Total Current Liabilities 7.0 6.7 5.1 6.5 11.8 8.8 22.0 37.9 14.8 25.1 3.9 2.9 10.7 3.3 3.2 1.8
Long Term Debt 0.3 0 0.2 0 0.2 43 K 0.1 0.3 (0.8) (0.3) 1.1 1.2 0.9 7.1 6.1 6.0
Deferred Tax Income 0 0 0 0 0 0 0 0 1.2 1.2 46 K 38 K 94 K 0 0 0
Other Liabilities 6.0 0 6.0 0 63.5 6.9 7.0 7.1 6.0 6.0 6.0 6.0 0 61.7 54.1 34.6
Total Liabilities 13.3 12.7 11.3 12.5 17.9 15.8 29.1 45.3 22.8 34.3 12.2 11.5 11.6 72.1 63.5 42.4
EQUITY
Common Stock 81 K 82 K 83 K 83 K 0.4 0.4 0.4 0.3 0.3 0.3 0.3 0.2 0.2 36 K 67 K 66 K
Retained Earnings (161.5) (127.5) (96.4) (66.0) (334.0) (291.0) (237.5) (165.5) (80.4) (33.1) (136.0) (104.8) (81.5) (63.4) (47.0) (37.5)
Other Accumulative Comprehensive Income/Loss 0 9 K 0 (129.0) (63.5) (7.0) (6.6) (5.7) (6.5) 0 0 0 0 (2.2) (1.6) (1.3)
Total Equity 27.3 59.6 89.0 116.6 78.9 115.1 151.6 129.5 195.8 203.8 58.3 17.9 36.8 (52.0) (40.8) (31.8)
Total Liabilities and Equity 40.6 72.3 100.3 129.0 96.8 130.9 180.7 174.7 218.5 238.1 70.6 29.4 48.4 20.1 22.7 10.6
SHARES OUTSTANDING
Common Shares Outstanding 8.1 8.4 8.3 6.8 0.1 4.1 3.5 3.2 3.2 3.1 2.8 2.3 0.7 1.6 1.6 1.6